Page last updated: 2024-08-24

triazoles and cenicriviroc

triazoles has been researched along with cenicriviroc in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertine, M; Brun-Vézinet, F; Charpentier, C; Collin, G; Damond, F; Descamps, D; Lefebvre, E; Matheron, S; Peytavin, G; Visseaux, B	1
Giesler, KE; Kim, MB; Liotta, DC; Tahirovic, YA; Truax, VM; Wilson, LJ	1

Reviews

1 review(s) available for triazoles and cenicriviroc

Article	Year
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. Expert opinion on investigational drugs, 2016, Volume: 25, Issue:12 Topics: Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Drug Design; HIV Infections; Humans; Imidazoles; Maraviroc; Sulfoxides; Triazoles	2016

Other Studies

1 other study(ies) available for triazoles and cenicriviroc

Article	Year
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates. PloS one, 2015, Volume: 10, Issue:8 Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cells, Cultured; Coculture Techniques; Cyclohexanes; HIV Infections; HIV-2; Humans; Imidazoles; Leukocytes, Mononuclear; Maraviroc; Phenotype; Phytohemagglutinins; Receptors, CCR2; Receptors, CCR5; Sulfoxides; Triazoles; Virus Replication	2015

Article

Year

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.

PloS one, 2015, Volume: 10, Issue:8

Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cells, Cultured; Coculture Techniques; Cyclohexanes; HIV Infections; HIV-2; Humans; Imidazoles; Leukocytes, Mononuclear; Maraviroc; Phenotype; Phytohemagglutinins; Receptors, CCR2; Receptors, CCR5; Sulfoxides; Triazoles; Virus Replication

2015